Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 27, 2010
The Chlamydia muridarum-induced IFN-β response is TLR3-dependent in murine oviduct epithelial cells
Wilbert A Derbigny, Raymond M Johnson, Katherine S Toomey, et al.
Mutation Research
|
January 27, 1999
The measurement of solar ultraviolet radiation
C R Roy, H P Gies, D J Lugg, et al.
Infection and Immunity
|
October 19, 2011
Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells
Wilbert A Derbigny, LaTasha R Shobe, Jasmine C Kamran, et al.
Breast Cancer Research and Treatment
|
December 28, 2014
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
N Elster, D M Collins, S Toomey, et al.
Clinical and Vaccine Immunology : CVI
|
November 17, 2012
An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models
Ciaran D Scallan, Debora W Tingley, Jonathan D Lindbloom, et al.
Journal of Neurosurgery
|
April 1, 1996
Posterior instrumentation of the unstable cervicothoracic spine
J R Chapman, P A Anderson, C Pepin, et al.
Microbial Ecology
|
December 23, 2006
Culturable microbial diversity and the impact of tourism in Kartchner Caverns, Arizona
Luisa A Ikner, Rickard S Toomey, Ginger Nolan, et al.
Physical Review Letters
|
February 9, 2005
Stalactite growth as a free-boundary problem: a geometric law and its platonic ideal
Martin B Short, James C Baygents, J Warren Beck, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
September 1, 1995
Cortical bone perfusion in plated fractured sheep tibiae
P J Kregor, D Senft, D Parvin, et al.
Breast Cancer Research and Treatment
|
December 22, 2014
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib
N Elster, M Cremona, C Morgan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of Immunology (Baltimore, Md. : 1950)
|
October 27, 2010
The Chlamydia muridarum-induced IFN-β response is TLR3-dependent in murine oviduct epithelial cells
Wilbert A Derbigny, Raymond M Johnson, Katherine S Toomey, et al.
Mutation Research
|
January 27, 1999
The measurement of solar ultraviolet radiation
C R Roy, H P Gies, D J Lugg, et al.
Infection and Immunity
|
October 19, 2011
Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells
Wilbert A Derbigny, LaTasha R Shobe, Jasmine C Kamran, et al.
Breast Cancer Research and Treatment
|
December 28, 2014
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
N Elster, D M Collins, S Toomey, et al.
Clinical and Vaccine Immunology : CVI
|
November 17, 2012
An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models
Ciaran D Scallan, Debora W Tingley, Jonathan D Lindbloom, et al.
Journal of Neurosurgery
|
April 1, 1996
Posterior instrumentation of the unstable cervicothoracic spine
J R Chapman, P A Anderson, C Pepin, et al.
Microbial Ecology
|
December 23, 2006
Culturable microbial diversity and the impact of tourism in Kartchner Caverns, Arizona
Luisa A Ikner, Rickard S Toomey, Ginger Nolan, et al.
Physical Review Letters
|
February 9, 2005
Stalactite growth as a free-boundary problem: a geometric law and its platonic ideal
Martin B Short, James C Baygents, J Warren Beck, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
September 1, 1995
Cortical bone perfusion in plated fractured sheep tibiae
P J Kregor, D Senft, D Parvin, et al.
Breast Cancer Research and Treatment
|
December 22, 2014
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib
N Elster, M Cremona, C Morgan, et al.
Page
of 3